IP Library Granted Patent US 7,056,338
Granted Patent B2
US 7,056,338 · App. 10/402,893 · Granted Jun 6, 2006

Therapeutic agent delivery device with controlled therapeutic agent release rates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,056,338
App. No.
10/402,893
Granted
Jun 6, 2006
Kind
B2
Abstract

The present invention relates to implantable medical devices for the localized delivery of therapeutic agents, such as drugs, to a patient. More particularly, the invention relates to a device having a gradient of water soluble therapeutic agents within a therapeutic agent layer and a mixing layer that allows for controlled release of the therapeutic agents.

Claims (36)

1. A method for preparing an implantable medical device, which method comprises:

a) providing an implantable medical device with a plurality of holes;

b) loading into the plurality of holes an amount of a liquefied therapeutic agent, which amount is sufficient to form a therapeutic agent layer;

c) allowing said liquefied therapeutic agent layer to at least partially solidify;

d) loading into the plurality of holes an amount of a liquefied bioresorbable polymer which amount is sufficient to liquefy a portion of the therapeutic agent layer, thereby allowing a portion of the therapeutic agent layer to be disposed within a mixing layer;

e) allowing said liquefied bioresorbable polymer and said portion of the therapeutic agent layer to solidify;

wherein a concentration of therapeutic agent contained within the mixing layer upon solidification is smaller than a concentration of therapeutic agent contained in the therapeutic agent layer;

wherein the loading of the liquefied therapeutic agent and the liquefied bioresorbable polymer are performed in a dropwise matter; and

further wherein steps d and e may optionally be repeated to form multiple mixing layers.

2. The method for preparing an implantable medical device of claim 1 , wherein the liquefied therapeutic agent is formed by dissolving the therapeutic agent in a solvent.

3. The method for preparing an implantable medical device of claim 1 , wherein the liquefied bioresorbable polymer is formed by dissolving the bioresorbable polymer in a solvent.

4. The method for preparing an implantable medical device of claim 1 , further comprising the step of forming a barrier layer by loading into the plurality of holes an amount of a liquefied biocompatible polymer, which amount is sufficient to form a barrier layer, wherein the barrier layer is located adjacent the therapeutic agent layer.

5. The method for preparing an implantable medical device of claim 4 , wherein the liquefied biocompatible polymer is liquefied by maintaining the biocompatible polymer at a temperature that is higher than its melting point, or glass transition temperature.

6. The method for preparing an implantable medical device of claim 4 , wherein the liquefied biocompatible polymer is formed by dissolving the biocompatible polymer in a solvent.

7. The method for preparing an implantable medical device of claim 1 , wherein the liquefied bioresorbable polymer loaded into the holes does not contain the therapeutic agent.

8. The method for preparing an implantable medical device of claim 1 , wherein the liquefied therapeutic agent layer comprises the therapeutic agent and a pharmaceutically acceptable polymer.

9. The method for preparing an implantable medical device of claim 8 , wherein the liquefied therapeutic agent layer comprises from about 50% to about 95% therapeutic agent and from about 5% to about 50% pharmaceutically acceptable polymer.

10. The method for preparing an implantable medical device of claim 1 , wherein the loading of the liquefied therapeutic agent and the liquefied bioresorbable polymer are performed by a piezoelectric micro-jetting device.

11. A method for preparing an implantable medical device, which method comprises:

a) providing an implantable medical device with a plurality of holes;

b) loading into the plurality of holes an amount of a liquefied therapeutic agent, which amount is sufficient to form a therapeutic agent layer;

c) allowing said liquefied therapeutic agent layer to at least partially solidify;

d) loading into the plurality of holes an amount of a liquefied bioresorbable polymer which amount is sufficient to liquefy a portion of the therapeutic agent layer, thereby allowing a portion of the therapeutic agent layer to be disposed within a mixing layer;

e) allowing said liquefied bioresorbable polymer and said portion of the therapeutic agent layer to solidify;

wherein a concentration of therapeutic agent contained within the mixing layer upon solidification is smaller than a concentration of therapeutic agent contained in the therapeutic agent layer;

further wherein steps d and e may optionally be repeated to form multiple mixing layers; and

wherein the liquefied therapeutic agent is liquefied by maintaining the therapeutic agent at a temperature that is higher than its melting point, or glass transition temperature.

12. A method for preparing an implantable medical device, which method comprises:

a) providing an implantable medical device with a plurality of holes;

b) loading into the plurality of holes an amount of a liquefied therapeutic agent, which amount is sufficient to form a therapeutic agent layer;

c) allowing said liquefied therapeutic agent layer to at least partially solidify;

d) loading into the plurality of holes an amount of a liquefied bioresorbable polymer which amount is sufficient to liquefy a portion of the therapeutic agent layer, thereby allowing a portion of the therapeutic agent layer to be disposed within a mixing layer;

e) allowing said liquefied bioresorbable polymer and said portion of the therapeutic agent layer to solidify;

wherein a concentration of therapeutic agent contained within the mixing layer upon solidification is smaller than a concentration of therapeutic agent contained in the therapeutic agent layer;

further wherein steps d and e may optionally be repeated to form multiple mixing layers; and

wherein the liquefied bioresorbable polymer is liquefied by maintaining the bioresorbable polymer at a temperature that is higher than its melting point, or glass transition temperature.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2009
From: CONOR MEDSYSTEMS, INC.
To: INNOVATIONAL HOLDINGS LLC
Reel/Frame 023538/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2007
From: CONOR MEDSYSTEMS, INC.
To: INNOVATIONAL HOLDINGS LLC
Reel/Frame 019955/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2003
From: SHANLEY, JOHN F.; PARKER, THEODORE L.
To: CONOR MEDSYSTEMS, INC.
Reel/Frame 014244/0016 →